DJIA 16,380.41 263.17 1.63%
NASDAQ 4,258.44 41.05 0.97%
S&P 500 1,886.76 24.00 1.29%
market minute promo

Biogen Idec (NASDAQ: BIIB)

306.71 3.97 (1.31%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $306.71 1.31%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $305.36
Previous Close $302.74
Daily Range $304.75 - $313.72
52-Week Range $230.25 - $358.89
Market Cap $72.4B
P/E Ratio 33.68
Dividend (Yield) $0.00 (0.0%)
Volume 1,782,161
Average Daily Volume 1,220,976
Current FY EPS $12.66

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary Rss Feed

This Drug Could Outsell Medical Marijuana

Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.

Baxter International: A Post-Earnings Buy As A Spin-Off Approaches

US IPO Weekly Recap: 5 IPOs achieve moderate gains during the market slide and a biotech rejection

3 Stocks Reiterated As A Buy: VZ, WMT, BIIB

3 Stocks Dragging In The Drugs Industry

Sustainability Pays: 3 Green Companies Making Money

Green companies needn't settle for sub-par performances, because sustainability can be profitable.

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

Forward Pharma goes backward: year's largest biotech drops 17% on IPO

Isis Pharmaceuticals Unveils Mid-Stage Data on ISIS-SMNRx - Analyst Blog

Which Fund Has The Most To Gain From Biogen Idec?

See More BIIB News...

BIIB's Top Competitors

BIIB $306.71 (1.31%)
Current stock: BIIB
GILD $100.75 (3.99%)
Current stock: GILD
CELG $88.12 (2.01%)
Current stock: CELG
$0.00 (0.00%)
Current stock: